sorafenib has been researched along with Allergy, Drug in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishiro, M; Honda, T; Ishigami, M; Ishikawa, T; Ishizu, Y; Ito, T; Kuzuya, T; Yoshioka, N | 1 |
| Blaziene, A; Chomiciene, A; Linauskiene, K; Malinauskiene, L; Vitkauskaite, E | 1 |
| Bertossi, M; De Sanctis, R; De Vincenzo, F; Di Tommaso, L; Fattuzzo, G; Giordano, L; Lorenzi, E; Mancini, L; Masci, G; Perrino, M; Rimassa, L; Roncalli, MG; Rubino, L; Santoro, A; Simonelli, M; Suter, MB; Zucali, PA; Zuradelli, M | 1 |
1 trial(s) available for sorafenib and Allergy, Drug
| Article | Year |
|---|---|
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Resistance, Neoplasm; Female; Humans; Lapatinib; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Niacinamide; Phenylurea Compounds; Quinazolines; Sorafenib | 2013 |
2 other study(ies) available for sorafenib and Allergy, Drug
| Article | Year |
|---|---|
Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Hypersensitivity; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Pyridines; Sorafenib | 2019 |
Severe adverse skin reaction and desensitization to sorafenib.
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Growth Processes; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Immune Tolerance; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib; Urticaria; Young Adult | 2016 |